Quantcast

Posts related to ‘GPCB’

The Day In Biotech Stocks (January 15, 2008) (DNA, DNDN, GENZ, TTHI, LCBM, CEGE, GPCB, CGEN)

Posted: January 15, 2008 at 7:07 pm

Today was a brutal day for risk stocks, and biotechs are often thought of as risky to stocks as Russian Roulette is to your head.  But Biotechs are also a ...
Read Full Story »

Failed Cancer Drug Trial Drives GPC Biotech (GPCB) Down 62%

Posted: October 31, 2007 at 7:42 am

Shares of GPC Biotech (GPCB) are off 62% before the open. GPCB announced that the Phase 3 SPARC trial evaluating satraplatin for the treatment of hormone-refractory prostate cancer did not ...
Read Full Story »

GPC Biotech (GPCB) Shares Now Cut In Half

Posted: July 25, 2007 at 8:43 am

Small biotechs, perhaps the most dangerous shares in the market GPC Biotech (GPCB) is down 33% today to $13.63. It is down by more than half from $37.79, its 52-week ...
Read Full Story »

Pre-Market Stock News (June 25, 2007)

Posted: June 25, 2007 at 7:18 am

(AAPL) Apple’s iTunes passed Amazon.com in music sales to become #3 music seller behind Best Buy and Wal-Mart.(AFOP) Alliance Fiber Optics raised Q2 sales guidance.(AGN) Allergan trades ex-split to reflect ...
Read Full Story »

Biotechs & Pharmas Bracing For ASCO Annual Meeting

Posted: May 30, 2007 at 6:30 pm

This weekend we have the mother of all future cancer treatment conferences: ASCO, or The American Society of Clinical Oncology.  Cancer stocks in the last few weeks have been seeing ...
Read Full Story »